Please check your internet connection and try again.
# Megacv Duo (Amoxicillin/Clavulanate Potassium)
## Overview
Megacv Duo is a combination antibiotic consisting of amoxicillin (a beta-lactam) and clavulanate potassium (a beta-lactamase inhibitor). The addition of clavulanate expands the spectrum of activity to include beta-lactamase-producing organisms.
## Primary Indications
Used for infections caused by susceptible organisms, including:
* Acute bacterial rhinosinusitis
* Community-acquired pneumonia
* Lower respiratory tract infections
* Acute otitis media
* Skin and skin structure infections (specifically bite wounds)
* Urinary tract infections
## Adult Dosing
* **Standard dosing:** 500 mg/125 mg orally every 8 hours or 875 mg/125 mg orally every 12 hours.
* **Severe infection/Respiratory tract:** 875 mg/125 mg every 12 hours.
* *Note:* Do not use the 875 mg tablet for patients with severe renal impairment (CrCl < 30 mL/min).
## Pediatric Dosing
* **General infection:** 20 mg/kg/day to 45 mg/kg/day (based on amoxicillin component) divided every 12 hours, depending on severity and local susceptibility patterns.
* **Otitis Media:** 80–90 mg/kg/day (based on amoxicillin component) divided every 12 hours (typically using the 7:1 ratio suspension).
* *Maximum:* Follow specific product concentration limits; do not exceed adult dosing.
## Dose Adjustments
* **Renal Impairment:** If CrCl is 10–30 mL/min, administer every 12 hours. If CrCl < 10 mL/min, administer every 24 hours. The 875 mg strength should be avoided in renal impairment.
* **Hepatic Impairment:** Use with caution; monitor hepatic function periodically.
## Contraindications
* History of amoxicillin/clavulanate-associated cholestatic jaundice or hepatic dysfunction.
* Known hypersensitivity to penicillins or any component of the formulation.
* Severe renal impairment (CrCl < 30 mL/min) for the 875 mg tablet.
## Adverse Effects
* **Common:** Diarrhea (frequently associated with the clavulanate component), nausea, vomiting, abdominal pain, oral candidiasis (thrush).
* **Serious:** Anaphylaxis, *Clostridioides difficile*-associated diarrhea (CDAD), hepatotoxicity (cholestatic jaundice), and skin rashes (Stevens-Johnson syndrome).
## Key Drug Interactions
* **Warfarin:** May increase anticoagulation effect (INR); monitor closely.
* **Methotrexate:** May decrease renal excretion of methotrexate, increasing toxicity risk.
* **Probenecid:** Decreases renal excretion of amoxicillin, increasing serum levels.
* **Oral Contraceptives:** Potential for reduced efficacy (though clinical evidence is inconsistent; recommend backup contraception).
## Monitoring
* Assess for resolution of infection symptoms.
* Monitor for signs of hypersensitivity (skin rash, wheezing).
* Periodic assessment of hepatic and renal function during prolonged therapy.
* Monitor stool frequency to screen for *C. difficile* infection.
## Clinical Pearls
* **Administration:** Take with food or a meal to reduce gastrointestinal upset and enhance absorption.
* **Dosing Ratio:** Commercially available formulations vary in their amoxicillin-to-clavulanate ratios (e.g., 2:1 vs 7:1). Ensure the correct strength is selected to minimize clavulanate-induced diarrhea while maintaining efficacy.
* **Uncertainty:** Dosing for specific pathogens or resistant organisms often depends on local antibiograms; consult ID guidelines or local hospital protocols.
***
**Educational Disclaimer:** This information is for educational purposes only. Always verify dosages, contraindications, and drug interactions against the most current prescribing information (e.g., package insert) or local clinical protocols before prescribing or administering medication.
